March 9, 2023 Experience Marsh McLennan $600 million senior notes offering We advised Marsh McLennan on its investment-grade notes offering
March 7, 2023 Experience VF €1 billion senior notes offering, including €500 million in green bonds We advised VF on the investment-grade debt offering
February 10, 2023 Experience CureVac $250 million follow-on offering We advised CureVac on the equity offering
February 7, 2023 Experience Roivant Sciences $230 million stock offering We advised the company on its SEC-registered offering
January 27, 2023 Experience Pacific Biosciences $201.25 million follow-on offering The shares are listed on the Nasdaq Global Select Market
November 10, 2022 Experience Roivant Sciences $150 million equity offering We advised the company on its debut SEC-registered primary and secondary offering
October 31, 2022 Experience Marsh McLennan $1 billion senior notes offering We advised Marsh McLennan on its investment-grade notes offering
September 19, 2022 Experience Roivant Sciences $400 million at-the-market offering We advised the company on an SEC-registered at-the-market offering
July 28, 2022 Experience CSX $2 billion senior notes offering We advised CSX on the investment-grade debt offering
July 12, 2022 Experience Tuya global offering and dual primary listing on the Hong Kong Stock Exchange We advised Tuya Inc. on its HK$141 million global offering and dual primary listing on the HKEX